659 related articles for article (PubMed ID: 33893219)
1. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
[TBL] [Abstract][Full Text] [Related]
2. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
3. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
Aulston B; Liu Q; Mante M; Florio J; Rissman RA; Yuan SH
J Alzheimers Dis; 2019; 72(2):575-585. PubMed ID: 31594233
[TBL] [Abstract][Full Text] [Related]
5. Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.
Usenovic M; Niroomand S; Drolet RE; Yao L; Gaspar RC; Hatcher NG; Schachter J; Renger JJ; Parmentier-Batteur S
J Neurosci; 2015 Oct; 35(42):14234-50. PubMed ID: 26490863
[TBL] [Abstract][Full Text] [Related]
6. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
7. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity.
Wegmann S; Maury EA; Kirk MJ; Saqran L; Roe A; DeVos SL; Nicholls S; Fan Z; Takeda S; Cagsal-Getkin O; William CM; Spires-Jones TL; Pitstick R; Carlson GA; Pooler AM; Hyman BT
EMBO J; 2015 Dec; 34(24):3028-41. PubMed ID: 26538322
[TBL] [Abstract][Full Text] [Related]
8. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
9. The Alzheimer Disease-Causing Presenilin-1 L435F Mutation Causes Increased Production of Soluble Aβ43 Species in Patient-Derived iPSC-Neurons, Closely Mimicking Matched Patient Brain Tissue.
Oakley DH; Chung M; Klickstein N; Commins C; Hyman BT; Frosch MP
J Neuropathol Exp Neurol; 2020 Jun; 79(6):592-604. PubMed ID: 32388561
[TBL] [Abstract][Full Text] [Related]
10. High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy.
Cheng C; Reis SA; Adams ET; Fass DM; Angus SP; Stuhlmiller TJ; Richardson J; Olafson H; Wang ET; Patnaik D; Beauchamp RL; Feldman DA; Silva MC; Sur M; Johnson GL; Ramesh V; Miller BL; Temple S; Kosik KS; Dickerson BC; Haggarty SJ
Sci Rep; 2021 Aug; 11(1):17029. PubMed ID: 34426604
[TBL] [Abstract][Full Text] [Related]
11. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
[TBL] [Abstract][Full Text] [Related]
12. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.
Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG
Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942
[TBL] [Abstract][Full Text] [Related]
13. Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.
Parra Bravo C; Giani AM; Madero-Perez J; Zhao Z; Wan Y; Samelson AJ; Wong MY; Evangelisti A; Cordes E; Fan L; Ye P; Zhu D; Pozner T; Mercedes M; Patel T; Yarahmady A; Carling GK; Sterky FH; Lee VMY; Lee EB; DeTure M; Dickson DW; Sharma M; Mok SA; Luo W; Zhao M; Kampmann M; Gong S; Gan L
Cell; 2024 May; 187(10):2446-2464.e22. PubMed ID: 38582079
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.
Nieznanska H; Boyko S; Dec R; Redowicz MJ; Dzwolak W; Nieznanski K
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166209. PubMed ID: 34246750
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses.
Podvin S; Jones A; Liu Q; Aulston B; Ransom L; Ames J; Shen G; Lietz CB; Jiang Z; O'Donoghue AJ; Winston C; Ikezu T; Rissman RA; Yuan S; Hook V
Mol Cell Proteomics; 2020 Jun; 19(6):1017-1034. PubMed ID: 32295833
[TBL] [Abstract][Full Text] [Related]
16. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
[TBL] [Abstract][Full Text] [Related]
17. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
[TBL] [Abstract][Full Text] [Related]
18. What is the evidence that tau pathology spreads through prion-like propagation?
Mudher A; Colin M; Dujardin S; Medina M; Dewachter I; Alavi Naini SM; Mandelkow EM; Mandelkow E; Buée L; Goedert M; Brion JP
Acta Neuropathol Commun; 2017 Dec; 5(1):99. PubMed ID: 29258615
[TBL] [Abstract][Full Text] [Related]
19. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission.
Chen C; Kumbhar R; Wang H; Yang X; Gadhave K; Rastegar C; Kimura Y; Behensky A; Kotha S; Kuo G; Katakam S; Jeong D; Wang L; Wang A; Chen R; Zhang S; Jin L; Workman CJ; Vignali DAA; Pletinkova O; Jia H; Peng W; Nauen DW; Wong PC; Redding-Ochoa J; Troncoso JC; Ying M; Dawson VL; Dawson TM; Mao X
Adv Sci (Weinh); 2024 Apr; 11(16):e2303775. PubMed ID: 38327094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
